• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症诊断中的分子标志物

Molecular markers in cancer diagnosis.

作者信息

Sidransky D

机构信息

Johns Hopkins University School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Baltimore, MD 21205-2196, USA.

出版信息

J Natl Cancer Inst Monogr. 1995(17):27-9.

PMID:8573448
Abstract

Clonal genetic alterations are a hallmark of human cancer pathogenesis. These genetic alterations may include specific gene mutations that drive the cancer process or phenotypic changes such as microsatellite instability that may be caused by specific genetic events. Identification of clonal cell populations that share a specific genetic alteration is virtually synonymous with the detection of cancer. These clonal cells can be detected among a large population of normal cells from limited clinical samples by DNA amplification techniques. Because of their unprecedented sensitivity and specificity, these approaches offer new hope for the early diagnosis of human cancer.

摘要

克隆性基因改变是人类癌症发病机制的一个标志。这些基因改变可能包括驱动癌症进程的特定基因突变,或可能由特定基因事件引起的表型变化,如微卫星不稳定性。识别共享特定基因改变的克隆细胞群体实际上等同于癌症检测。通过DNA扩增技术,可以在来自有限临床样本的大量正常细胞中检测到这些克隆细胞。由于其前所未有的敏感性和特异性,这些方法为人类癌症的早期诊断带来了新希望。

相似文献

1
Molecular markers in cancer diagnosis.癌症诊断中的分子标志物
J Natl Cancer Inst Monogr. 1995(17):27-9.
2
The potential of molecular screening.
Surg Oncol Clin N Am. 1999 Oct;8(4):641-56, vi.
3
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.COLD-PCR:用于显著提高癌症突变检测和基因检测的新平台。
Biochem Soc Trans. 2009 Apr;37(Pt 2):427-32. doi: 10.1042/BST0370427.
4
Genetic alterations as clonal markers for bladder cancer detection in urine.作为尿液中膀胱癌检测克隆标志物的基因改变
J Cell Biochem Suppl. 1996;25:191-6.
5
Multiple detection of genetic alterations in tumors and stool.肿瘤和粪便中基因改变的多重检测
Clin Cancer Res. 2001 Mar;7(3):590-3.
6
Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.用于诊断微小残留头颈癌的分子检测方法:方法、可靠性、陷阱及解决方案
Clin Cancer Res. 2000 Oct;6(10):3803-16.
7
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.通过微卫星分型和p53突变分析检测头颈部鳞状细胞癌中的血浆肿瘤DNA
Cancer Res. 2000 Feb 1;60(3):707-11.
8
Highly selective isolation of unknown mutations in diverse DNA fragments: toward new multiplex screening in cancer.高度选择性分离不同DNA片段中的未知突变:迈向癌症新的多重筛选
Cancer Res. 2000 Jul 15;60(14):3732-7.
9
Detection of sequential genetic alterations relevant for breast cancer development.与乳腺癌发展相关的序列基因改变的检测。
Eur J Cancer Prev. 1996 Dec;5(6):497-503.
10
Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations.通过p53基因突变和微卫星改变检测发现乳腺纤维腺瘤不存在基因异常。
Cancer Res. 2001 Nov 1;61(21):7955-8.

引用本文的文献

1
Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions.细胞学与分子生物学在口腔癌前病变或恶性病变诊断中的应用。
Mol Cancer. 2006 Mar 23;5:11. doi: 10.1186/1476-4598-5-11.